Arax Advisory Partners’s First Trust Indxx Medical Devices ETF MDEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,082
Closed -$42.8K 4038
2025
Q2
$42.8K Hold
2,082
﹤0.01% 1314
2025
Q1
$42K Sell
2,082
-28,021
-93% -$591K ﹤0.01% 1014
2024
Q4
$619K Buy
30,103
+2,146
+8% +$46K 0.04% 247
2024
Q3
$622K Buy
27,957
+4,040
+17% +$84.3K 0.06% 164
2024
Q2
$475K Buy
23,917
+1,561
+7% +$31.9K 0.05% 204
2024
Q1
$478K Buy
22,356
+10,514
+89% +$217K 0.05% 183
2023
Q4
$239K Buy
11,842
+8,574
+262% +$156K 0.03% 266
2023
Q3
$58.9K Buy
3,268
+1,550
+90% +$30.6K 0.01% 431
2023
Q2
$36K Buy
1,718
+396
+30% +$8.17K ﹤0.01% 506
2023
Q1
$26.9K Buy
1,322
+1,201
+993% +$23.7K ﹤0.01% 538
2022
Q4
$2.27K Hold
121
﹤0.01% 925
2022
Q3
$2K Buy
+121
New +$2.24K ﹤0.01% 968

Other funds holding MDEV

Arax Advisory Partners's MDEV Position: Q3 2025 in Review

Arax Advisory Partners sold out of First Trust Indxx Medical Devices ETF (MDEV) in Q3 2025, closing a stake of 2,082 shares — an estimated $42.8K sold.

Arax Advisory Partners first reported a position in MDEV in Q3 2022 and held it in 12 quarters. The position peaked at $622K in Q3 2024. 3 funds tracked by Wall St. Rank hold MDEV as of Q3 2025.

  • Arax Advisory Partners reported no remaining First Trust Indxx Medical Devices ETF position as of Q3 2025 after selling out during the quarter.
  • Arax Advisory Partners sold 2,082 First Trust Indxx Medical Devices ETF shares in Q3 2025, an estimated $42.8K.
  • Arax Advisory Partners first reported a position in First Trust Indxx Medical Devices ETF in Q3 2022 and held it in 12 quarters.
  • Arax Advisory Partners's First Trust Indxx Medical Devices ETF position peaked at $622K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held First Trust Indxx Medical Devices ETF as of Q3 2025.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.